Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
publishing date : 2022 - 02 - 18 symbols : Sny save search
Global Bladder Cancer Drug Market (2021 to 2026) - Unhygienic Workplace Exposure and Increase in Smoking Habits is Driving Growth
Published: 2022-02-18 (Crawled : 21:00) - prnewswire.com
JNJ | News | $148.53 -0.69% -0.14% 9.6M
|
Health Technology
| Email alert
Add to watchlist
SNYNF | News | $94.25 -2.18% 480
|
Health Technology
| Email alert
Add to watchlist
SNY | News | $46.66 -2.16% -2.21% 1.7M
|
Health Technology
| Email alert
Add to watchlist
bladder cancer drug work cancer drug cancer growth bladder
$26.7 Billion Adult Vaccine Market Outlook, 2027 Featuring Key Players - GSK, Merck & Co, Sanofi Pasteur, Pfizer, and CSL Limited
Published: 2022-02-18 (Crawled : 19:00) - prnewswire.com
SNY | News | $46.66 -2.16% -2.21% 1.7M
|
Health Technology
| Email alert
Add to watchlist
GSK | News | $40.86 -0.92% -0.15% 1.7M
|
Health Technology
| Email alert
Add to watchlist
PFE | News 4 | $26.27 -0.19% -0.15% 23M
|
Health Technology
| Email alert
Add to watchlist
SNYNF | News | $94.25 -2.18% 480
|
Health Technology
| Email alert
Add to watchlist
GLAXF | News | $19.54 -14.18% 2.6K
|
Health Technology
| Email alert
Add to watchlist
vaccine
OSE Immunotherapeutics Announces Appointment of Alexandre Lebeaut as an Independent Member of the Board of Directors
Published: 2022-02-18 (Crawled : 18:00) - globenewswire.com
SNYNF | News | $94.25 -2.18% 480
|
Health Technology
|
| O: -0.23%
H: 0.0%
C: -6.31%
SNY | News | $46.66 -2.16% -2.21% 1.7M
|
Health Technology
|
| O: -0.47%
H: 0.77%
C: -0.23%
ces therapeutics
Sanofi, Regeneron Suffer Rare Dupixent Flop in CSU
Published: 2022-02-18 (Crawled : 16:00) - biospace.com/
SNYNF | News | $94.25 -2.18% 480
|
Health Technology
|
| O: -0.23%
H: 0.0%
C: -6.31%
SNY | News | $46.66 -2.16% -2.21% 1.7M
|
Health Technology
|
| O: -0.47%
H: 0.77%
C: -0.23%
rare dupixent
With Market Size Valued at $6.5 Billion by 2026, it`s a Healthy Outlook for the Global Throat Lozenges Market
Published: 2022-02-18 (Crawled : 16:00) - prnewswire.com
RBGPF | News | $52.06 6.46% 4.8K
|
Consumer Non-Durables
|
| O: 3.87%
H: 0.0%
C: -3.44%
GLAXF | News | $19.54 -14.18% 2.6K
|
Health Technology
|
| O: 0.0%
H: 0.0%
C: -2.14%
SNYNF | News | $94.25 -2.18% 480
|
Health Technology
|
| O: -0.23%
H: 0.0%
C: -6.31%
RBGLY | News | $10.59 -2.05% 850K
|
Manufacturing
|
| O: 3.3%
H: 0.4%
C: -0.97%
GSK | News | $40.86 -0.92% -0.15% 1.7M
|
Health Technology
|
| O: -0.46%
H: 0.46%
C: -0.19%
SNY | News | $46.66 -2.16% -2.21% 1.7M
|
Health Technology
|
| O: -0.47%
H: 0.77%
C: -0.23%
health
BioSpace Movers & Shakers, Feb. 18
Published: 2022-02-18 (Crawled : 14:00) - biospace.com/
SNYNF | News | $94.25 -2.18% 480
|
Health Technology
|
| O: -0.23%
H: 0.0%
C: -6.31%
JNJ | News | $148.53 -0.69% -0.14% 9.6M
|
Health Technology
|
| O: -0.73%
H: 0.23%
C: -0.98%
VXRT | News | $0.7051 -5.41% -5.72% 1.5M
|
Health Technology
|
| O: 0.0%
H: 2.95%
C: 0.21%
SNY | News | $46.66 -2.16% -2.21% 1.7M
|
Health Technology
|
| O: -0.47%
H: 0.77%
C: -0.23%
BMRN | $91.25 -0.88% -0.89% 1.6M
|
Health Technology
|
| O: -1.89%
H: 1.47%
C: -4.21%
ALEC | $5.27 -1.31% -1.33% 380K
|
Health Technology
|
| O: -0.37%
H: 3.37%
C: 2.06%
space spac
Azurity Pharmaceuticals Announces Richard Blackburn as New CEO
Published: 2022-02-18 (Crawled : 12:00) - biospace.com/
SNYNF | News | $94.25 -2.18% 480
|
Health Technology
|
| O: -0.23%
H: 0.0%
C: -6.31%
SNY | News | $46.66 -2.16% -2.21% 1.7M
|
Health Technology
|
| O: -0.47%
H: 0.77%
C: -0.23%
als ces new ceo ceo
Update on ongoing Dupixent® (dupilumab) chronic spontaneous urticaria Phase 3 program
Published: 2022-02-18 (Crawled : 09:00) - biospace.com/
SNYNF | News | $94.25 -2.18% 480
|
Health Technology
|
| O: -0.23%
H: 0.0%
C: -6.31%
SNY | News | $46.66 -2.16% -2.21% 1.7M
|
Health Technology
|
| O: -0.47%
H: 0.77%
C: -0.23%
REGN | News | $906.55 -0.09% -0.08% 370K
|
Health Technology
|
| O: -0.78%
H: 1.76%
C: -1.08%
dupixent ongoing program phase 3 urticaria
BioArctic continues to build its commercial organization
Published: 2022-02-18 (Crawled : 08:00) - prnewswire.com
SNYNF | News | $94.25 -2.18% 480
|
Health Technology
|
| O: -0.23%
H: 0.0%
C: -6.31%
JNJ | News | $148.53 -0.69% -0.14% 9.6M
|
Health Technology
|
| O: -0.73%
H: 0.23%
C: -0.98%
SNY | News | $46.66 -2.16% -2.21% 1.7M
|
Health Technology
|
| O: -0.47%
H: 0.77%
C: -0.23%
commercialization
Regeneron and Sanofi Provide Update on Ongoing Dupixent® (dupilumab) Chronic Spontaneous Urticaria Phase 3 Program
Published: 2022-02-18 (Crawled : 07:00) - prnewswire.com
SNYNF | News | $94.25 -2.18% 480
|
Health Technology
|
| O: -0.23%
H: 0.0%
C: -6.31%
SNY | News | $46.66 -2.16% -2.21% 1.7M
|
Health Technology
|
| O: -0.47%
H: 0.77%
C: -0.23%
REGN | News | $906.55 -0.09% -0.08% 370K
|
Health Technology
|
| O: -0.78%
H: 1.76%
C: -1.08%
dupixent ongoing program phase 3 urticaria
Gainers vs Losers
| 62% | 38% |
Top 10 Gainers
CSSE 4 | $0.4323 183.85% 64.77% 220M
|
Consumer Services
BOF | $1.99 70.09% 41.21% 110M
|
ILAG | $0.51 6.03% 40.62% 1.7M
|
LICN | $0.941 68.04% 40.49% 15M
|
AMST | $3.31 65.5% 39.58% 70M
|
Technology Services
MTC | $3.615 61.38% 38.04% 9.3M
|
Technology Services
WIMI | $1.15 58.53% 36.92% 19M
|
Technology Services
AIH | $0.45 12.5% 30.92% 320K
|
Health Services
MULN | News | $3.78 38.46% 27.78% 13M
|
Information
RILY | $29.86 37.48% 27.26% 12M
|
Finance
Your saved searches
Save your searches and get alerts when important news are released.